AT-21INTEGRATED (EPI)GENOMIC ANALYSES IDENTIFY SUB-GROUP SPECIFIC THERAPEUTIC TARGETS IN CNS RHABDOID TUMORS
Jonathon Torchia(University of Toronto), Annie Huang(Hospital for Sick Children), Brian Golbourn(University of Pittsburgh), Alexandre Vasiljevic(Centre de Recherche en Neurosciences de Lyon), Dalia Baršytė-Lovejoy(University Health Network), Louis Létourneau(BGI Group (China)), Joseph Norman(Hospital for Sick Children), Alexander R. Judkins(University of Southern California), Lucie Lafay‐Cousin(Women & Children's Hospital of Buffalo), Torsten Pietsch(University Hospital Bonn), King Ching Ho(Hospital for Sick Children), Shengrui Feng(University Health Network), James T. Rutka(Hospital for Sick Children), Maryam Fouladi(Nationwide Children's Hospital), Éric Bouffet(Hospital for Sick Children), Cynthia Hawkins(Hospital for Sick Children), Daniel D. De Carvalho(University Health Network), Nada Jabado(McGill University), Tiffany Sin Yu Chan(University of Toronto), Patrick Sin‐Chan(Regeneron (United States)), Daniel Picard(Heidelberg University), Lindsey M. Hoffman(St Nicholas Hospital), Natalia R. Agamez(Hospital for Sick Children), Dong Anh Khuong Quang(McGill University), Mei Lu(Hospital for Sick Children), Stefan Rutkowski(Universität Hamburg), Constanze Zeller(University Health Network), C.H. Arrowsmith(University Health Network)
Cited by 20
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Epigenetic protein families: a new frontier for drug discovery
|Nature Reviews Drug Discovery|2012|1.3k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k